203 related articles for article (PubMed ID: 11722319)
1. Familial occurrence of tardive dyskinesia.
Müller DJ; Schulze TG; Knapp M; Held T; Krauss H; Weber T; Ahle G; Maroldt A; Alfter D; Maier W; Nöthen MM; Rietschel M
Acta Psychiatr Scand; 2001 Nov; 104(5):375-9. PubMed ID: 11722319
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings.
Ismail B; Cantor-Graae E; McNeil TF
Schizophr Bull; 2001; 27(4):629-41. PubMed ID: 11824489
[TBL] [Abstract][Full Text] [Related]
3. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D3 receptor variant and tardive dyskinesia.
Rietschel M; Krauss H; Müller DJ; Schulze TG; Knapp M; Marwinski K; Maroldt AO; Paus S; Grünhage F; Propping P; Maier W; Held T; Nöthen MM
Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):31-5. PubMed ID: 10738862
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia presenting as a psychosis.
Asnis GM; Nathan RS; Davies SO; Halbreich U
J Nerv Ment Dis; 1979 Dec; 167(12):762-3. PubMed ID: 41884
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
[TBL] [Abstract][Full Text] [Related]
7. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
9. High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia.
Lerner V; Miodownik C; Kaptsan A; Vishne T; Sela BA; Levine J
J Clin Psychiatry; 2005 Dec; 66(12):1558-63. PubMed ID: 16401157
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF
Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342
[TBL] [Abstract][Full Text] [Related]
11. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.
Lai IC; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY; Wang YC
Neuropsychobiology; 2002; 46(4):173-5. PubMed ID: 12566932
[TBL] [Abstract][Full Text] [Related]
12. Familial tardive dyskinesia.
Yassa R; Ananth J
Am J Psychiatry; 1981 Dec; 138(12):1618-9. PubMed ID: 6118067
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
[TBL] [Abstract][Full Text] [Related]
14. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
15. Familial occurrence of tardive dyskinesia.
Weinhold P; Wegner JT; Kane JM
J Clin Psychiatry; 1981 Apr; 42(4):165-6. PubMed ID: 6110655
[TBL] [Abstract][Full Text] [Related]
16. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
Gałecki P; Pietras T; Szemraj J
Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
[TBL] [Abstract][Full Text] [Related]
17. Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
World J Biol Psychiatry; 2011 Mar; 12(2):143-8. PubMed ID: 20726823
[TBL] [Abstract][Full Text] [Related]
18. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
[TBL] [Abstract][Full Text] [Related]
19. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia: reversible and irreversible.
Casey DE
Psychopharmacology Suppl; 1985; 2():88-97. PubMed ID: 2860664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
